本页面由Tiger Trade Technology Pte. Ltd.提供服务

NovoCure Limited

14.72
+0.14000.96%
盘后:14.720.00000.00%16:26 EDT
成交量:78.20万
成交额:1,144.60万
市值:17.14亿
市盈率:-11.25
高:14.76
开:14.54
低:14.26
收:14.58
52周最高:21.45
52周最低:9.82
股本:1.16亿
流通股本:9,642.36万
量比:0.35
换手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
净资产收益率:-43.22%
总资产收益率:-9.26%
市净率:5.07
市盈率(LYR):-12.05

数据加载中...

2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities